Glucagon like Peptide 1 News and Research

RSS
SGLT-2 Inhibitors May Lower Dementia Risk in Type 2 Diabetes Patients, Study Finds

SGLT-2 Inhibitors May Lower Dementia Risk in Type 2 Diabetes Patients, Study Finds

Emerging Treatments and Drug Repositioning for NAFLD and NASH

Emerging Treatments and Drug Repositioning for NAFLD and NASH

Chemist Develops Potential Drug To Treat Type 2 Diabetes Without Harsh Side Effects

Chemist Develops Potential Drug To Treat Type 2 Diabetes Without Harsh Side Effects

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.